Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Magnus Ingelman-Sundberg

Showing results (211-220 of 263) with videos related to

Pageof 27
Sort By:
Breast Cancer Research : BCR|November 11, 2005
CYP17 gene polymorphism in relation to breast cancer risk: a case-control studyKristjana Einarsdóttir, Tove Rylander-Rudqvist, Keith Humphreys, et al.
Atherosclerosis|August 24, 2005
Common polymorphisms in the CYP7A1 gene do not contribute to variation in rates of bile acid synthesis and plasma LDL cholesterol concentrationAnna Abrahamsson, Sergey Krapivner, Ulf Gustafsson, et al.
European Journal of Clinical Pharmacology|October 20, 2011
Omeprazole limited sampling strategies to predict area under the concentration-time curve ratios: implications for cytochrome P450 2C19 and 3A phenotypingEileen B Lawson, Jerry C Wu, R Michael Baldwin, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|February 16, 2008
Generation of mice transgenic for human CYP2C18 and CYP2C19: characterization of the sexually dimorphic gene and enzyme expressionSusanne Löfgren, R Michael Baldwin, Masahiro Hiratsuka, et al.
Biochemical and Biophysical Research Communications|November 5, 2005
Role of the conserved threonine 309 in mechanism of oxidation by cytochrome P450 2D6Peter H J Keizers, Loek H M Schraven, Chris de Graaf, et al.
European Journal of Clinical Pharmacology|July 29, 2010
Linkage disequilibrium between the CYP2C19*17 allele and wildtype CYP2C8 and CYP2C9 alleles: identification of CYP2C haplotypes in healthy Nordic populationsRasmus S Pedersen, Charlotte Brasch-Andersen, Sarah C Sim, et al.
Clinical Pharmacology and Therapeutics|May 1, 2019
Development of the PGx-Passport: A Panel of Actionable Germline Genetic Variants for Pre-Emptive Pharmacogenetic TestingCathelijne H van der Wouden, Mandy H van Rhenen, Wafa O M Jama, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|August 30, 2011
Human embryonic stem cell derived hepatocyte-like cells as a tool for in vitro hazard assessment of chemical carcinogenicityReha Yildirimman, Gabriella Brolén, Mireia Vilardell, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|April 11, 2009
Xenobiotic-metabolizing enzymes and transporters in the normal human brain: regional and cellular mapping as a basis for putative roles in cerebral functionFabien Dutheil, Sandrine Dauchy, Monique Diry, et al.
Clinical Pharmacology and Therapeutics|April 23, 2020
Clinically Relevant Cytochrome P450 3A4 Induction Mechanisms and Drug Screening in Three-Dimensional Spheroid Cultures of Primary Human HepatocytesDelilah F G Hendriks, Sabine U Vorrink, Tomas Smutny, et al.
Pageof 27

Showing results (211-220 of 263) with videos related to

Sort By:
Pageof 27
Breast Cancer Research : BCR|November 11, 2005
CYP17 gene polymorphism in relation to breast cancer risk: a case-control studyKristjana Einarsdóttir, Tove Rylander-Rudqvist, Keith Humphreys, et al.
Atherosclerosis|August 24, 2005
Common polymorphisms in the CYP7A1 gene do not contribute to variation in rates of bile acid synthesis and plasma LDL cholesterol concentrationAnna Abrahamsson, Sergey Krapivner, Ulf Gustafsson, et al.
European Journal of Clinical Pharmacology|October 20, 2011
Omeprazole limited sampling strategies to predict area under the concentration-time curve ratios: implications for cytochrome P450 2C19 and 3A phenotypingEileen B Lawson, Jerry C Wu, R Michael Baldwin, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|February 16, 2008
Generation of mice transgenic for human CYP2C18 and CYP2C19: characterization of the sexually dimorphic gene and enzyme expressionSusanne Löfgren, R Michael Baldwin, Masahiro Hiratsuka, et al.
Biochemical and Biophysical Research Communications|November 5, 2005
Role of the conserved threonine 309 in mechanism of oxidation by cytochrome P450 2D6Peter H J Keizers, Loek H M Schraven, Chris de Graaf, et al.
European Journal of Clinical Pharmacology|July 29, 2010
Linkage disequilibrium between the CYP2C19*17 allele and wildtype CYP2C8 and CYP2C9 alleles: identification of CYP2C haplotypes in healthy Nordic populationsRasmus S Pedersen, Charlotte Brasch-Andersen, Sarah C Sim, et al.
Clinical Pharmacology and Therapeutics|May 1, 2019
Development of the PGx-Passport: A Panel of Actionable Germline Genetic Variants for Pre-Emptive Pharmacogenetic TestingCathelijne H van der Wouden, Mandy H van Rhenen, Wafa O M Jama, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|August 30, 2011
Human embryonic stem cell derived hepatocyte-like cells as a tool for in vitro hazard assessment of chemical carcinogenicityReha Yildirimman, Gabriella Brolén, Mireia Vilardell, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|April 11, 2009
Xenobiotic-metabolizing enzymes and transporters in the normal human brain: regional and cellular mapping as a basis for putative roles in cerebral functionFabien Dutheil, Sandrine Dauchy, Monique Diry, et al.
Clinical Pharmacology and Therapeutics|April 23, 2020
Clinically Relevant Cytochrome P450 3A4 Induction Mechanisms and Drug Screening in Three-Dimensional Spheroid Cultures of Primary Human HepatocytesDelilah F G Hendriks, Sabine U Vorrink, Tomas Smutny, et al.
Pageof 27